Use access key #2 to skip to page content.
$53.92 -0.68 (-1.25%)
7/23/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

0

Avatar benz536 (40.41) Submitted: 5/07/08 1:33 PM : Outperform Start Price: $42.13 AMGN Score: 37.00

At year low, has good pipeline oversold

Report this Post Replies: 0 | Reply

Featured Broker Partners